God is our Guide  Number 1 site for helping reverse diseases on Planet Earth
 

CIDPUSA.ORG

 
Home
Diagnosis
Treatment
Pathology
Variants
Natural makeup
Diet
IVIG
Celiac Disease Guide
Celiac Disease Info
Celiac D Anatomy
Celiac D Story
Celiac Neurology
Celiac Mystery
Celiac Secrets
Autoimmune diseases

Homocysteine diet

 Scleroderma

Rheumatic diseases

Antibiotics for help

Causes of Burning feet

Neuropathy testing

Clay baths

Steaming Sand Baths

Sulfur Bath

Detox Baths

Colostrum

Hallelujah Diet

Caveman Diet

Anticancer Diet

Ketogenic Diet

Myasthenia Diet

Natural Diet for diseases

Fat lowering Diet

Lower Cholesterol

Libido Diet

 

 Restenois after smoking   CIDPUSA Foundation

   alternatives treatment of autoimmune disease read our e-book 

Special GoogleHealth Search
Circulation. 2001;104:773.) © 2001 American Heart Association, Inc.
 

Clinical Investigation and Reports on Smoking

Impact of Smoking on Clinical and Angiographic Restenosis After

 Percutaneous Coronary Intervention

Another Smoker’s Paradox?

From the Harvard Clinical Research Institute, Harvard Medical School (D.J.C., M.D., D.E.C., K.K.L.H., R.E.K.); Cardiovascular Division, Beth Israel Deaconess Medical Center (D.J.C., M.D., D.E.C., K.K.L.H.); and Divisions of Cardiology (J.J.P., R.E.K.) and Clinical Biometry (R.E.K.), Brigham and Women’s Hospital, Boston, Mass.

BackgroundRecent studies have suggested that smokers may require less frequent repeated revascularization after percutaneous coronary intervention (PCI) compared with nonsmokers. However, the mechanism of this phenomenon is unknown.

Methods and ResultsWe examined the association betweensmoking and restenosis using pooled data from 8671 patientstreated with PCI in 9 multicenter clinical trials. Clinicalrestenosis was examined in the cohort of 5682 patients who were assigned to clinical follow-up only. Angiographic restenosis was evaluated in the subset of 2989 patients who were assigned to mandatory angiographic restudy. Among those patients assigned to clinical follow-up only, target lesion revascularization (TLR) occurred in 6.6% of smokers and 10.1% of nonsmokers (P<0.001). After adjustment for baseline clinical and angiographic differences,the rate of TLR remained significantly lower in smokers withan adjusted relative risk of 0.69 (95% CI, 0.54 to 0.88). Among the angiographic cohort, there were no differences in the rates of angiographic restenosis or follow-up diameter stenosis in either univariate or multivariate analyses. This dissociation between clinical and angiographic restenosis was explained in part by reduced sensitivity to restenosis on the part of smokers and by the greater reluctance of smokers to seek medical attentiondespite recurrent angina.

Conclusions— In patients undergoing contemporary PCI,cigarette smoking is associated with a lower rate of subsequent TLR without affecting angiographic restenosis. These findings have important implications for the follow-up of smokers after PCI and suggest that cross-study comparisons of rates of clinical restenosis must account for the potential confounding effect of smoking.


Key Words:
angioplasty • stents • smoking • restenosis

  • Andrikopoulos, G. K., Chimonas, E. T., Toutouzas, P. K., Cohen, D. J., Doucet, M., Cutlip, D. E., Ho, K. K.L., Popma, J. J., Kuntz, R. E. (2002).